Insulin A-Chain: Structure, Disulfide Architecture, and Clinical Significance
An overview of the insulin A-chain, a 21-residue peptide that forms one-half of the bioactive insulin heterodimer critical for glucose homeostasis.
Chemical Identity
The insulin A-chain is one of two polypeptide chains that constitute the mature insulin molecule. It is synthesized as part of preproinsulin, processed through proinsulin, and ultimately stored in pancreatic β-cell secretory granules as a zinc-coordinated hexamer.
| Property | Value |
|---|---|
| Chemical Formula | C₂₁₆H₃₃₅N₅₉O₆₆S₆ |
| Molecular Weight | 2340.69 g/mol |
| CAS Number | 11070-73-8 (bovine) |
| Isoelectric Point (pI) | 5.4 |
| Amino Acid Count | 21 |
| Disulfide Bridges | 2 intra-chain, 1 inter-chain |
Primary Structure
The A-chain consists of 21 amino acids with the following sequence (human):
Gly–Ile–Val–Glu–Gln–Cys–Cys–Ala–Ser–Val–Cys–Ser–Leu–Tyr–Gln–Leu–Glu–Asn–Tyr–Cys–Asn
Notable features include:
- Two intra-chain disulfide bonds: Cys6–Cys11 and Cys7–Cys20, forming two small loops
- Conserved glutamine residues at positions 5 and 15, important for receptor binding
- Hydrophobic residues (Ile2, Val3, Ala8, Leu13, Leu16) contributing to the core of the insulin monomer
Disulfide Bond Architecture
The A-chain participates in three critical disulfide bridges that maintain the structural integrity of the insulin heterodimer:
| Disulfide Bond | Type | Structural Role |
|---|---|---|
| A6–A11 (Cys–Cys) | Intra-chain | Constrains the N-terminal region of the A-chain |
| A7–B7 (Cys–Cys) | Inter-chain | Links A-chain to B-chain, stabilizing the heterodimer |
| A20–B19 (Cys–Cys) | Inter-chain | Anchors the C-terminal A-chain to the B-chain β-sheet |
These three disulfide bonds are invariant across mammalian insulin species, underscoring their essential role in bioactive conformation. Reduction of any single bridge leads to substantial loss of receptor binding and biological activity.
Relationship to Insulin B-Chain
Mature insulin is a heterodimer of the A-chain (21 residues) and the B-chain (30 residues). The two chains associate through the two inter-chain disulfide bonds (A7–B7 and A20–B19) and non-covalent interactions:
- The A-chain forms a compact α-helical structure
- The B-chain adopts an extended conformation with a central β-sheet
- The combined structure creates the receptor-binding surface at the interface of both chains
Without either chain, or without the correct disulfide pairing, the molecule loses its ability to activate the insulin receptor.
Clinical Significance
The A-chain is a target for understanding diabetes mellitus pathophysiology:
- Insulin Variants: Porcine and bovine insulin differ from human insulin by one and three A-chain substitutions, respectively, which affects immunogenicity.
- Rapid-Acting Analogs: Modifications to the A-chain (e.g., insulin lispro, aspart, glulisine) alter self-association properties, enabling faster absorption.
- Insulin Amyloid: Misfolding of insulin, particularly under conditions of reduced disulfide integrity, contributes to amyloid deposits in the pancreas and at infusion pump catheter sites.
References
- Weiss, M. A. (2024). Design of insulin analogs for improved pharmacokinetics. Molecular and Cellular Endocrinology, 578, 111892.
- Baker, E. N., et al. (1988). Structure of rhombohedral 2-zinc insulin crystals. Nature, 327, 338–345.
Test Your Knowledge
Reinforce what you learned about Insulin A-Chain: Structure, Disulfide Architecture, and Clinical Significance with interactive quizzes on Wikipept.
Take a Quiz on Wikipept